FogPharma Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boston, MA USA
Total Funding:$112.6M
Lead Investor(s):6 Dimensions Capital

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • FogPharma's estimated annual revenue is currently $11.2M per year.(?)
  • FogPharma received $66.0M in venture funding in May 2018.
  • FogPharma's estimated revenue per employee is $155,000
  • FogPharma's total funding is $112.6M.

Employee Data

  • FogPharma has 72 Employees.(?)
  • FogPharma grew their employee count by 18% last year.
  • FogPharma currently has 12 job openings.

FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered undruggable. The company's cell-penetrating miniproteins (CPMPs) combine the targeting power of protein therapeutics with the cell-penetrating ability of small molecules. This unique combination of targeting features enables CPMP's to access and engage proteins that have long been known to play a major role in causing serious human diseases, but have been frustratingly beyond the reach of therapeutic intervention. We are a vibrant and driven group of scientists and science lovers, with a strong entrepreneurial spirit, and deeply committed to our mission of adding years to life and life to years through the creation of transformative new medicines.